Indefinite Delivery Contract SPE2DX15D9100

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) under its Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at up to $499,999,999, allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide.

The contract encompasses the delivery of a vast array of pharmaceutical products, including both common and specialized medications across multiple therapeutic classes, to support the diverse medical requirements of military personnel and their dependents at various Department of Defense (DoD) healthcare facilities. Specific products supplied under this IDC include, but are not limited to, flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptive products, oncology drugs, and specialty medications for rare diseases. The IDC complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, further solidifying the company's role as a critical provider of pharmaceutical solutions to the military health system.